{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:57:20Z","timestamp":1793156240072,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T00:00:00Z","timestamp":1566259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010552","name":"Departament de Salut, Generalitat de Catalunya","doi-asserted-by":"publisher","award":["SLT006\/17\/00127"],"award-info":[{"award-number":["SLT006\/17\/00127"]}],"id":[{"id":"10.13039\/501100010552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jmoldx.2019.06.010","type":"journal-article","created":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T20:43:19Z","timestamp":1566420199000},"page":"1010-1024","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer"],"prefix":"10.1016","volume":"21","author":[{"given":"Sol\u00e8ne M.","family":"Evrard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Taranchon-Clermont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Rouquette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Dintner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Chung","family":"Nam-Apostolopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Bellosillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Varela-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Nadal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus H.","family":"Wiedorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linea","family":"Melchior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Andrew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Ridgway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Frykman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Lind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitja","family":"Rot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izidor","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst J.M.","family":"Speel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido M.J.M.","family":"Roemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol","family":"Trincheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra N.","family":"Freiberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Rechsteiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2019.06.010_bib1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib2","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"Eur J\u00a0Cancer"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib3","first-page":"7","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J\u00a0Clin"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib4","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fonc.2017.00194","article-title":"Smoking and lung cancer: a geo-regional perspective","volume":"7","author":"Rahal","year":"2017","journal-title":"Front Oncol"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib5","doi-asserted-by":"crossref","first-page":"448.e2","DOI":"10.1016\/j.ccr.2012.03.007","article-title":"SnapShot: non-small cell lung cancer","volume":"21","author":"Heist","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib6","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1056\/NEJMra0707704","article-title":"EGFR antagonists in cancer treatment","volume":"358","author":"Ciardiello","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib7","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1001\/jama.2014.3314","article-title":"Epidermal growth factor receptor tyrosine kinase inhibitors vs conventional chemotherapy in non-small cell lung cancer harboring wild-type epidermal growth factor receptor: a meta-analysis","volume":"311","author":"Lee","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib8","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0959-8049(01)00230-1","article-title":"The EGFR family and its ligands in human cancer: signalling mechanisms and therapeutic opportunities","volume":"37 Suppl 4","author":"Yarden","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrclinonc.2009.62","article-title":"Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC","volume":"6","author":"Linardou","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib10","doi-asserted-by":"crossref","first-page":"75ra26","DOI":"10.1126\/scitranslmed.3002003","article-title":"Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors","volume":"3","author":"Sequist","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib11","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S1470-2045(09)70110-X","article-title":"EGFR testing in lung cancer is ready for prime time","volume":"10","author":"Hirsch","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib12","first-page":"1595","article-title":"EGFR mutations as a prognostic and predictive marker in non-small-cell lung cancer","volume":"8","author":"Fang","year":"2014","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib13","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.3892\/or.2017.5409","article-title":"Determining EGFR-TKI sensitivity of G719X and other uncommon EGFR mutations in non-small cell lung cancer: perplexity and solution (review)","volume":"37","author":"Li","year":"2017","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1158\/1078-0432.CCR-09-1660","article-title":"Somatic EGFR mutation and gene copy gain as predictive biomarkers for response to tyrosine kinase inhibitors in non-small cell lung cancer","volume":"16","author":"Dahabreh","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib15","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/jnci\/djt072","article-title":"Impact of EGFR inhibitor in non-small cell lung cancer on progression-free and overall survival: a meta-analysis","volume":"105","author":"Lee","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib16","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1200\/JCO.2012.43.4522","article-title":"Role of epidermal growth factor receptor inhibitors in epidermal growth factor receptor wild-type non-small-cell lung cancer","volume":"31","author":"Laurie","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib17","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/S1470-2045(11)70129-2","article-title":"EGFR exon 20 insertion mutations in non-small-cell lung cancer: preclinical data and clinical implications","volume":"13","author":"Yasuda","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib18","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/annonc\/mdw326","article-title":"ESMO Guidelines Committee: Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27 Suppl 5","author":"Novello","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib19","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1200\/JCO.2017.76.7293","volume":"36","author":"Kalemkerian","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib20","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/annonc\/mdu145","article-title":"Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer","volume":"25","author":"Kerr","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib21","series-title":"NCCN Guidelines Version 1.2018. Non-Small Cell Lung Cancer","author":"NCCN","year":"2017"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib22","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJMoa1411817","article-title":"AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer","volume":"372","author":"J\u00e4nne","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib23","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1200\/JCO.2017.74.7576","article-title":"Osimertinib as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer","volume":"36","author":"Ramalingam","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer","volume":"378","author":"Soria","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2011.10.017","article-title":"The challenge of NSCLC diagnosis and predictive analysis on small samples: practical approach of a working group","volume":"76","author":"Thunnissen","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1200\/JCO.2012.43.1718","article-title":"Use of research biopsies in clinical trials: are risks and benefits adequately discussed?","volume":"31","author":"Overman","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib27","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jmoldx.2018.04.002","article-title":"Validity of targeted next-generation sequencing in routine care for identifying clinically relevant molecular profiles in non-small-cell lung cancer: results of a 2-year experience on 1343 samples","volume":"20","author":"Legras","year":"2018","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib28","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1093\/annonc\/mdx404","article-title":"Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) program","volume":"28","author":"Leduc","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib29","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/bjc.2014.353","article-title":"Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing","volume":"111","author":"Patton","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib30","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1097\/JTO.0b013e3181f1c8de","article-title":"Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop","volume":"5","author":"Pirker","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib31","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/annonc\/mdx629","article-title":"Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project","volume":"29","author":"Kerr","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib32","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.lungcan.2017.11.005","article-title":"A comprehensive review of uncommon EGFR mutations in patients with non-small cell lung cancer","volume":"114","author":"Tu","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib33","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3892\/ijmm.2014.1789","article-title":"A comparison of epidermal growth factor receptor mutation testing methods in different tissue types in non-small cell lung cancer","volume":"34","author":"Yi","year":"2014","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib34","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1515\/cclm-2017-0112","article-title":"Sample types applied for molecular diagnosis of therapeutic management of advanced non-small cell lung cancer in the precision medicine","volume":"55","author":"Han","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib35","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/JTO.0b013e3181a94af4","article-title":"Discordance of molecular biomarkers associated with epidermal growth factor receptor pathway between primary tumors and lymph node metastasis in non-small cell lung cancer","volume":"4","author":"Park","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib36","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1256930","article-title":"Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing","volume":"346","author":"Zhang","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib37","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s40291-014-0115-2","article-title":"Cytosine deamination is a major cause of baseline noise in next-generation sequencing","volume":"18","author":"Chen","year":"2014","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.jmoldx.2019.06.010_bib38","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jclinpath-2018-205197","article-title":"Idylla assay and next generation sequencing: an integrated EGFR mutational testing algorithm","volume":"71","author":"De Luca","year":"2018","journal-title":"J Clin Pathol"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157819303551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157819303551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:13:30Z","timestamp":1761502410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157819303551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1525157819303551"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2019.06.010","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2019.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}